2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(1S,4aS,5R,6R,8aR)-decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methy lene-4-pentenyl)-1-naphthalenyl]methyl ester, (2E)- - Names and Identifiers
Name | 8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
|
Synonyms | 8Α-HYDROXYLABDA-13(16),14-DIEN- 8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate 8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnaMate 8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate 2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(1S,4aS,5R,6R,8aR)-decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methy lene-4-pentenyl)-1-naphthalenyl]methyl ester, (2E)- 2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(1S,4aS,5R,6R,8aR)-decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methylene-4-penten-1-yl)-1-naphthalenyl]methyl ester, (2E)-
|
CAS | 117254-98-5
|
2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(1S,4aS,5R,6R,8aR)-decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methy lene-4-pentenyl)-1-naphthalenyl]methyl ester, (2E)- - Physico-chemical Properties
Molecular Formula | C29H40O4
|
Molar Mass | 452.63 |
Density | 1.063±0.06 g/cm3(Predicted) |
Melting Point | 218 °C |
Boling Point | 571.1±25.0 °C(Predicted) |
Appearance | Powder |
pKa | 9.69±0.26(Predicted) |
Storage Condition | 2-8℃ |
MDL | MFCD23103726 |
2-Propenoic acid, 3-(4-hydroxyphenyl)-, [(1S,4aS,5R,6R,8aR)-decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methy lene-4-pentenyl)-1-naphthalenyl]methyl ester, (2E)- - Introduction
8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate, also known as 8α-hydroxyllabaren-13 (16),14-dien-19-yl p-hydroxycinnamate (8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate).
The properties of the compound are as follows:
-Appearance: Colorless to yellow crystalline solid
-Molecular formula: C30H38O4
-Molecular weight: 462.63g/mol
Use of 8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate:
-Cosmetics: Because of its antioxidant and anti-inflammatory effects, it can be used as an additive in skin care products to help reduce skin aging and inflammation.
-Drug research: Studies have shown that the compound has anti-tumor, anti-inflammatory, antibacterial and other activities, and may be used to develop new drugs.
Production of 8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate:
It can be obtained by esterification of the corresponding compound with P-hydroxycinnamic acid ester in an appropriate solvent.
Regarding the safety information of this compound, there are relatively few studies on its toxicity and safety, so more research is needed to determine its comprehensive safety information. General laboratory guidelines should be followed when using or handling the compound, and inhalation, skin contact, or ingestion should be avoided. In case of discomfort or accident, medical assistance should be sought immediately.
Last Update:2024-04-09 21:54:55